These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 11463988
1. Filgrastim (r-metHuG-CSF) in the 21st century: SD/01. Morstyn G, Foote MA, Walker T, Molineux G. Acta Haematol; 2001; 105(3):151-5. PubMed ID: 11463988 [Abstract] [Full Text] [Related]
2. Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy. Johnston E, Crawford J, Blackwell S, Bjurstrom T, Lockbaum P, Roskos L, Yang BB, Gardner S, Miller-Messana MA, Shoemaker D, Garst J, Schwab G. J Clin Oncol; 2000 Jul; 18(13):2522-8. PubMed ID: 10893282 [Abstract] [Full Text] [Related]
3. Biopharmaceutical drug development: Filgrastim (r-metHuG-CSF) use in patients with HIV infection. Foote M, Welch W. J Hematother Stem Cell Res; 1999 Jul; 8 Suppl 1():S3-8. PubMed ID: 10596029 [Abstract] [Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic profile of new biosimilar filgrastim XM02 equivalent to marketed filgrastim Neupogen: single-blind, randomized, crossover trial. Lubenau H, Bias P, Maly AK, Siegler KE, Mehltretter K. BioDrugs; 2009 Jul; 23(1):43-51. PubMed ID: 19344191 [Abstract] [Full Text] [Related]
7. Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropenia. Ricotta R, Cerea G, Schiavetto I, Maugeri MR, Pedrazzoli P, Siena S. Future Oncol; 2006 Dec; 2(6):667-76. PubMed ID: 17155894 [Abstract] [Full Text] [Related]
10. Granulocyte colony stimulating factor significantly influences neutrophil recovery and duration of hospitalisation in bone marrow transplantation. Teoh GK, Tan PH, Goh YT. Ann Acad Med Singap; 1994 Nov; 23(6):823-7. PubMed ID: 7537949 [Abstract] [Full Text] [Related]
11. Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors. Sivgin S, Karakus E, Keklik M, Zararsiz G, Solmaz M, Kaynar L, Eser B, Cetin M, Unal A. Transfus Apher Sci; 2016 Jun; 54(3):410-5. PubMed ID: 27052362 [Abstract] [Full Text] [Related]
13. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor. Cottle TE, Fier CJ, Donadieu J, Kinsey SE. Semin Hematol; 2002 Apr; 39(2):134-40. PubMed ID: 11957197 [Abstract] [Full Text] [Related]
14. Evidence that the granulocyte colony-stimulating factor (G-CSF) receptor plays a role in the pharmacokinetics of G-CSF and PegG-CSF using a G-CSF-R KO model. Kotto-Kome AC, Fox SE, Lu W, Yang BB, Christensen RD, Calhoun DA. Pharmacol Res; 2004 Jul; 50(1):55-8. PubMed ID: 15082029 [Abstract] [Full Text] [Related]